Mohanapriya Chinambedu Dhandapani1, Vettriselvi Venkatesan2, Nammalwar Bollam Rengaswamy3, Kalpana Gowrishankar4, Sudha Ekambaram3, Prabha Sengutavan5, Venkatachalam Perumal6. 1. V Clin Bio Labs, Central Research Facility, Sri Ramachandra University, Porur, Chennai, 600 116, India. 2. Department of Human Genetics, Sri Ramachandra University, Porur, Chennai, 600 116, India. 3. Department of Pediatric Nephrology, Mehta Children's Hospital, Chennai, 600 031, India. 4. Department of Medical Genetics, Kanchi Kamakoti CHILDS Trust Hospital, Chennai, 600 034, India. 5. Department of Nephrology, Sri Ramachandra University, Porur, Chennai, 600 116, India. 6. Department of Human Genetics, Sri Ramachandra University, Porur, Chennai, 600 116, India. venkip@yahoo.com.
Abstract
BACKGROUND: Steroid-resistant nephrotic syndrome (SRNS) is found in 10-20 % of children with idiopathic nephrotic syndrome (INS). In SRNS patients, common histopathological subtypes are Focal segmental glomerulosclerosis (FSGS) (53 %) and minimal change disease (MCD) (27 %). Familial forms of FSGS constitute podocyte diseases with varying severity and age of onset. Podocin gene (NPHS2) mutations cause childhood-onset steroid-resistant FSGS and MCD to adult-onset FSGS. In view of genetic variations and susceptibility to the disease, the present investigation was undertaken to study the pattern of genetic mutation in children from South India. METHODS: Mutation analysis was carried out by direct sequencing of the entire NPHS2 gene (eight exons) using specific primers in 200 INS (100 SRNS and 100 steroid sensitive) children and 100 healthy controls. The allele and genotype frequencies of NPHS2 gene were calculated for both cases and controls as per Hardy-Weinberg equilibrium. RESULTS: Among the SRNS patients, 18 % revealed both heterozygous and homozygous mutations. Out of 12 mutations, 8 were homozygous and 4 were heterozygous. Interestingly, we found two novel SNPs in exon 4 of NPHS2 gene, which are documented and submitted to dbsnp database (Ref rs12401711 and rs12401708). CONCLUSION: Mutational analysis of NPHS2 would be advisable at the start of treatment. The genetic variations detected in the study would serve as the important molecular marker in treating the children's at early stage, which also enables to detect carriers, prenatal diagnosis and provide genetic counseling to couples at risk.
BACKGROUND:Steroid-resistant nephrotic syndrome (SRNS) is found in 10-20 % of children with idiopathic nephrotic syndrome (INS). In SRNS patients, common histopathological subtypes are Focal segmental glomerulosclerosis (FSGS) (53 %) and minimal change disease (MCD) (27 %). Familial forms of FSGS constitute podocyte diseases with varying severity and age of onset. Podocin gene (NPHS2) mutations cause childhood-onset steroid-resistant FSGS and MCD to adult-onset FSGS. In view of genetic variations and susceptibility to the disease, the present investigation was undertaken to study the pattern of genetic mutation in children from South India. METHODS: Mutation analysis was carried out by direct sequencing of the entire NPHS2 gene (eight exons) using specific primers in 200 INS (100 SRNS and 100 steroid sensitive) children and 100 healthy controls. The allele and genotype frequencies of NPHS2 gene were calculated for both cases and controls as per Hardy-Weinberg equilibrium. RESULTS: Among the SRNS patients, 18 % revealed both heterozygous and homozygous mutations. Out of 12 mutations, 8 were homozygous and 4 were heterozygous. Interestingly, we found two novel SNPs in exon 4 of NPHS2 gene, which are documented and submitted to dbsnp database (Ref rs12401711 and rs12401708). CONCLUSION: Mutational analysis of NPHS2 would be advisable at the start of treatment. The genetic variations detected in the study would serve as the important molecular marker in treating the children's at early stage, which also enables to detect carriers, prenatal diagnosis and provide genetic counseling to couples at risk.
Authors: Hiroyasu Tsukaguchi; Akulapalli Sudhakar; Tu Cam Le; Trang Nguyen; Jun Yao; Joshua A Schwimmer; Asher D Schachter; Esteban Poch; Patricia F Abreu; Gerald B Appel; Aparecido B Pereira; Raghu Kalluri; Martin R Pollak Journal: J Clin Invest Date: 2002-12 Impact factor: 14.808
Authors: N Boute; O Gribouval; S Roselli; F Benessy; H Lee; A Fuchshuber; K Dahan; M C Gubler; P Niaudet; C Antignac Journal: Nat Genet Date: 2000-04 Impact factor: 38.330
Authors: Gianluca Caridi; Roberta Bertelli; Alba Carrea; Marco Di Duca; Paolo Catarsi; Mary Artero; Michele Carraro; Cristina Zennaro; Giovanni Candiano; Luca Musante; Marco Seri; Fabrizio Ginevri; Francesco Perfumo; Gian Marco Ghiggeri Journal: J Am Soc Nephrol Date: 2001-12 Impact factor: 10.121
Authors: Rainer G Ruf; Anne Lichtenberger; Stephanie M Karle; Johannes P Haas; Franzisco E Anacleto; Michael Schultheiss; Isabella Zalewski; Anita Imm; Eva-Maria Ruf; Bettina Mucha; Arvind Bagga; Thomas Neuhaus; Arno Fuchshuber; Aysin Bakkaloglu; Friedhelm Hildebrandt Journal: J Am Soc Nephrol Date: 2004-03 Impact factor: 10.121
Authors: Mara Sanches Guaragna; Anna Cristina G B Lutaif; Andréa T Maciel-Guerra; Vera M S Belangero; Gil Guerra-Júnior; Maricilda P De Mello Journal: Biomed Res Int Date: 2017-07-12 Impact factor: 3.411